| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |